Longer duration of thalidomide monotherapy results in improved outcome in relapsed/refractory multiple myeloma

被引：2
|
作者：
von Liliefifeld-Toal, Marie [1 ]
Hahn-Ast, Corinna [1 ]
Bertolini, Francesco
Bila, Jelena
Boulin, Mathieu
Oakervee, Heather
Cibeira, Teresa
Cook, Gordon
Dmoszynska, Anna
Fenk, Roland
Guglielmelli, Tommasina
Goldschmidt, Hartmut
Hattori, Yukata
Myers, Bethan
Offidani, Massimo
Patriarca, Francesca
Petrucci, Maria Teresa
Pini, Massimo
Prince, Miles
Schey, Steve
Sonneveld, Pieter
Yakoub-Agha, Ibrahim
Waage, Anders
Glasmacher, Axel [1 ]
机构：
[1] Univ Bonn, D-5300 Bonn, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2725.2725
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2725
引用
收藏
页码：800A / 800A
页数：1
相关论文
共 50 条
  • [31] Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma
    Zemanova, M.
    Scudla, V.
    Adam, Z.
    Gregora, E.
    Pour, L.
    Minarik, J.
    Pavlicek, P.
    Pika, T.
    Bacovsky, J.
    NEOPLASMA, 2008, 55 (04) : 345 - 349
  • [32] Thalidomide treatment for relapsed/refractory multiple myeloma: A retrospective multicenter study.
    Bibas, M
    Andriani, A
    Ferrari, A
    Montanaro, M
    Niscola, G
    Recine, U
    Chierichini, A
    BLOOD, 2001, 98 (11) : 307B - 307B
  • [33] LOW-DOSE THALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kohei, K. O.
    Ando, S.
    Hasino, S.
    Huse, H.
    Morita, R.
    Takahata, M.
    Onozawa, M.
    Kahata, K.
    Kondo, T.
    Ota, S.
    Kawamura, T.
    Kurosawa, M.
    Aikawa, K.
    Ogawa, T.
    Suzuki, S.
    Takahashi, S.
    Izumiyama, K.
    Iwasaki, H.
    Maemori, M.
    Sakai, H.
    Asaka, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 619 - 620
  • [34] Low-dosed thalidomide regimens in therapy of relapsed or refractory multiple myeloma
    Zemanova, M.
    Scudla, V.
    Pour, L.
    Gregora, E.
    Pavlicek, P.
    Minarik, J.
    Pika, T.
    Bacovsky, J.
    Adam, Z.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 174 - 174
  • [35] Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study
    Kumar, Shaji
    Vij, Ravi
    Kaufman, Jonathan L.
    Mikhael, Joseph
    Facon, Thierry
    Pegourie, Brigitte
    Benboubker, Lofti
    Gasparetto, Cristina
    Amiot, Martine
    Moreau, Philippe
    Alzate, Stefanie
    Ross, Jeremy
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh
    Leverson, Joel
    Maciag, Paulo
    Verdugo, Maria
    Touzeau, Cyrille
    BLOOD, 2016, 128 (22)
  • [36] Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia
    Cook, Gordon
    Corso, Alessandro
    Streetly, Matthew
    Mendeleeva, Larisa P.
    Ptushkin, Vadim V.
    Chan, Edmond
    Ukropec, Jon
    Iraqi, Wafae
    Al-Akabawi, Assem
    Pei, Huiling
    Gaudig, Maren
    Petrucci, Maria Teresa
    Alegre, Adrian
    Mateos, Maria-Victoria
    ONCOLOGY AND THERAPY, 2021, 9 (01) : 139 - 151
  • [37] Salvage therapy with thalidomide for patients with advanced relapsed/refractory multiple myeloma.
    Tosi, P
    Ronconi, S
    Zamagni, E
    Cellini, C
    Tura, S
    Cavo, M
    BLOOD, 2000, 96 (11) : 296B - 296B
  • [38] Vorinostat, Bortezomib, Cyclophosphomide, Thalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
    Gleason, Charise
    Kaufman, Jonathan L.
    Nooka, Ajay K.
    Valla, Kelly
    Heffner, Leonard T.
    Bisht, Aditya Singh
    Manubolu, Sanjay
    Watson, Melanie
    Boise, Lawrence H.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
  • [39] Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma
    Alegre, Adrian
    de la Rubia, Javier
    Sureda Balari, Anna
    Encinas Rodriguez, Cristina
    Suarez, Alexia
    Jesus Blanchard, Maria
    Bargay Lleonart, Joan
    Rodriguez-Otero, Paula
    Insunza, Andres
    Palomera, Luis
    Jesus Penarrubia, Maria
    Rios-Tamayo, Rafael
    Casado Montero, Luis Felipe
    Sonia Gonzalez, Marta
    Potamianou, Anna
    Couturier, Catherine
    Pei, Huiling
    Hevia, Henar
    Milionis, Iordanis
    Gaudig, Maren
    Mateos, Maria-Victoria
    HEMASPHERE, 2020, 4 (03):
  • [40] Very low doses of thalidomide as single agent in relapsed/refractory multiple myeloma
    Guglielmelli, Tommasina
    Capella, Sara
    Saglio, Giuseppe
    ACTA HAEMATOLOGICA, 2006, 116 (01) : 70 - 71
12345